tirzepatide and nad+ Compounded Weight Loss Program | GLP-1 Treatment NAD+ vs Peptides: Differences, Combining

Description

improved cardiovascular outcomes and reduction of cardiovascular diseases have also been observed in recent clinical trials

For comparison against the PlexusDx Weight Management Protocols using identical compounded molecules: Microdose GLP-1 Protocol is $129/month flat ($1,548/year roughly $2,016/year less than Henry), Semaglutide Injection runs $149/mo ($2,148$2,748/year), Tirzepatide Injection runs $249/mo ($2,748$3,708/year), and GLP-Squared dual-compound therapy is $249/mo ($2,148$3,900/year)

Here, we show that improved glucose metabolism in hypothyroid mice after T3 treatment is accompanied with increased glucagon-like peptide-1 (GLP-1) production and insulin secretion, while co-treatment with a GLP-1 receptor antagonist attenuates the effects of T3 on insulin and glucose levels